MRK vs. AMGN
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Amgen Inc. (AMGN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or AMGN.
Correlation
The correlation between MRK and AMGN is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. AMGN - Performance Comparison
Key characteristics
MRK:
-1.31
AMGN:
0.17
MRK:
-1.74
AMGN:
0.44
MRK:
0.76
AMGN:
1.06
MRK:
-0.86
AMGN:
0.19
MRK:
-1.92
AMGN:
0.46
MRK:
15.52%
AMGN:
9.54%
MRK:
22.76%
AMGN:
25.79%
MRK:
-68.62%
AMGN:
-78.04%
MRK:
-34.62%
AMGN:
-11.84%
Fundamentals
MRK:
$218.92B
AMGN:
$159.46B
MRK:
$6.74
AMGN:
$7.56
MRK:
12.84
AMGN:
39.24
MRK:
0.18
AMGN:
2.09
MRK:
$48.59B
AMGN:
$33.32B
MRK:
$36.68B
AMGN:
$20.46B
MRK:
$19.73B
AMGN:
$13.31B
Returns By Period
In the year-to-date period, MRK achieves a -13.88% return, which is significantly lower than AMGN's 13.21% return. Over the past 10 years, MRK has underperformed AMGN with an annualized return of 7.57%, while AMGN has yielded a comparatively higher 9.81% annualized return.
MRK
-13.88%
-15.16%
-23.46%
-29.83%
4.85%
7.57%
AMGN
13.21%
9.20%
-7.20%
4.65%
8.88%
9.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. AMGN — Risk-Adjusted Performance Rank
MRK
AMGN
MRK vs. AMGN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. AMGN - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.64%, more than AMGN's 3.05% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.64% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
AMGN Amgen Inc. | 3.05% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% | 1.53% |
Drawdowns
MRK vs. AMGN - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, smaller than the maximum AMGN drawdown of -78.04%. Use the drawdown chart below to compare losses from any high point for MRK and AMGN. For additional features, visit the drawdowns tool.
Volatility
MRK vs. AMGN - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 10.71% compared to Amgen Inc. (AMGN) at 8.45%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. AMGN - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities